2-Ethoxy-4-[2-oxo-2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]ethyl]benzoic acid

CAS: 107362-12-9

Ref. 3D-IE21210

Información del producto

• Nombre: 2-Ethoxy-4-[2-oxo-2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]ethyl]benzoic acid
• Sinónimos: 2-Desisopropyl-2-phenyl repaglinideRepaglinide related compound CRepaglinide Impurity
• Marca: Biosynth
• Descripción: 2-Ethoxy-4-[2-oxo-2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]ethyl]benzoic acid is a drug product that has not yet been approved for use in humans. It is currently undergoing research and development to determine its safety, efficacy, and optimal dosage range. 2EtOBA has shown pharmacological activity in animal models of inflammation and pain. 2EtOBA is metabolized by esterases, glutathione reductase, cytochrome P450 enzymes, reduction by glutathione reductase or conjugation with glucuronic acid. The metabolite of 2EtOBA is the parent compound with a different side chain. This impurity standard can be used in HPLC methods to measure the concentration of this metabolite.

Propiedades químicas

• Peso molecular: 486.6 g/mol
• Fórmula: C₃₀H₃₄N₂O₄
• Pureza: Min. 95%
• InChI: InChI=1S/C30H34N2O4/c1-2-36-28-20-23(15-16-25(28)30(34)35)21-29(33)31-26(19-22-11-5-3-6-12-22)24-13-7-8-14-27(24)32-17-9-4-10-18-32/h3,5-8,11-16,20,26H,2,4,9-10,17-19,21H2,1H3,(H,31,33)(H,34,35)
• Clave InChI: InChIKey=MHMMEOVDUOZDJA-UHFFFAOYSA-N
• SMILES: CCOc1cc(CC(=O)NC(Cc2ccccc2)c2ccccc2N2CCCCC2)ccc1C(=O)O